Allogeneic CMV-Specific CD19-CAR T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic CMV-Specific CD19-CAR T Cells, covering 2025-11-12 to 2025-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia [EARLY_Phase 1]